Lack of ADAM2, CALR3 and SAGE1 Cancer/Testis Antigen Expression in Lung and Breast Cancer.

about

Lack of ADAM2, CALR3 and SAGE1 Cancer/Testis Antigen Expression in Lung and Breast Cancer.

Item

http://www.wikidata.org/entity/Q35739798

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Lack of ADAM2, CALR3 and SAGE1 ...... ion in Lung and Breast Cancer.

@ast

Lack of ADAM2, CALR3 and SAGE1 ...... ion in Lung and Breast Cancer.

@en

type

Item

label

Lack of ADAM2, CALR3 and SAGE1 ...... ion in Lung and Breast Cancer.

@ast

Lack of ADAM2, CALR3 and SAGE1 ...... ion in Lung and Breast Cancer.

@en

prefLabel

Lack of ADAM2, CALR3 and SAGE1 ...... ion in Lung and Breast Cancer.

@ast

Lack of ADAM2, CALR3 and SAGE1 ...... ion in Lung and Breast Cancer.

@en

P1476

Lack of ADAM2, CALR3 and SAGE1 Cancer/Testis Antigen Expression in Lung and Breast Cancer

@en

P2093

Christina B Pedersen

http://www.w3.org/2001/XMLSchema#string

Emeaga Maheswaran

http://www.w3.org/2001/XMLSchema#string

P2860

Identification on a human sarcoma of two new genes with tumor-specific expression

Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses

Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines

Cancer/testis antigens, gametogenesis and cancer

Treatment of ovarian cancer cell lines with 5-aza-2'-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules.

Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes.

MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies.

Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma.

Novel antigens in non-small cell lung cancer: SP17, AKAP4, and PTTG1 are potential immunotherapeutic targets.

Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer.

P304

e0134967

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0134967

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Henrik J. Ditzel

Morten F Gjerstorff

P577

2015-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280969002

http://www.w3.org/2001/XMLSchema#string

P698

26252478

http://www.w3.org/2001/XMLSchema#string

P932

4529184

http://www.w3.org/2001/XMLSchema#string